A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
Thal LJ; Ferris SH; Kirby L; Block GA; Lines CR; Yuen E; Assaid C; Nessly ML; Norman BA; Baranak CC; Reines SA; Neuropsychopharmacology: Official Publication Of The American College Of Neuropsychopharmacology, 2005, vol. 30, issue 6, p 1204, ISSN 0893133x. ISBN 0893133x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef